OIS at AAO 2015

ForSight VISION5

Nov 12, 2015 8:38am ‐ Nov 12, 2015 8:46am


ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major eye diseases. The lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually.


You must be logged in and own this session in order to post comments.